Kim, Hyung-Don
Choi, Eugene
Shin, Jinho
Lee, In-Seob
Ko, Chang Seok
Ryu, Min-Hee
Park, Young Soo
Article History
Received: 28 August 2023
Accepted: 9 November 2023
First Online: 16 November 2023
Competing interests
: M.R. received honoraria from DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly, Ono Pharmaceutical, MSD, Taiho Pharmaceutical, Novartis, Daiichi Sankyo and AstraZeneca, and served as a consultant for DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly and Ono Pharmaceutical. H.K. received honoraria from AstraZeneca, Bristol Myers Squibb, Ono Pharmaceuticals, Boryung Pharmaceuticals, and Boostimmune; and served as a consultant for Mustbio. E.C., J.S., I.L., C.K and Y.P. declare no competing interests.